Global Active Transdermal Drug Delivery Device Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Active Transdermal Drug Delivery Device will have significant change from previous year. According to our (LP Information) latest study, the global Active Transdermal Drug Delivery Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Active Transdermal Drug Delivery Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Active Transdermal Drug Delivery Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Active Transdermal Drug Delivery Device market, reaching US$ million by the year 2028. As for the Europe Active Transdermal Drug Delivery Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Active Transdermal Drug Delivery Device players cover Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., and Johnson & Johnson (Janssen Pharmaceuticals Inc.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Active Transdermal Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Active Transdermal Drug Delivery Device will have significant change from previous year. According to our (LP Information) latest study, the global Active Transdermal Drug Delivery Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Active Transdermal Drug Delivery Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Active Transdermal Drug Delivery Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Active Transdermal Drug Delivery Device market, reaching US$ million by the year 2028. As for the Europe Active Transdermal Drug Delivery Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Active Transdermal Drug Delivery Device players cover Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., and Johnson & Johnson (Janssen Pharmaceuticals Inc.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Active Transdermal Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Patches
- Gels
- Clinic
- Hospital
- Home Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis AG
- Noven Pharmaceuticals, Inc.
- Transdermal Corp.
- Johnson & Johnson (Janssen Pharmaceuticals Inc.)
- Mylan N.V.
- 3M
- Actavis, Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Corium International, Inc.
- Echo Therapeutics, Inc.
- GlaxoSmithKline plc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Active Transdermal Drug Delivery Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Active Transdermal Drug Delivery Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Active Transdermal Drug Delivery Device by Country/Region, 2017, 2022 & 2028
2.2 Active Transdermal Drug Delivery Device Segment by Type
2.2.1 Patches
2.2.2 Gels
2.3 Active Transdermal Drug Delivery Device Sales by Type
2.3.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
2.3.2 Global Active Transdermal Drug Delivery Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Active Transdermal Drug Delivery Device Sale Price by Type (2017-2022)
2.4 Active Transdermal Drug Delivery Device Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Home Use
2.5 Active Transdermal Drug Delivery Device Sales by Application
2.5.1 Global Active Transdermal Drug Delivery Device Sale Market Share by Application (2017-2022)
2.5.2 Global Active Transdermal Drug Delivery Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Active Transdermal Drug Delivery Device Sale Price by Application (2017-2022)
3 GLOBAL ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE BY COMPANY
3.1 Global Active Transdermal Drug Delivery Device Breakdown Data by Company
3.1.1 Global Active Transdermal Drug Delivery Device Annual Sales by Company (2020-2022)
3.1.2 Global Active Transdermal Drug Delivery Device Sales Market Share by Company (2020-2022)
3.2 Global Active Transdermal Drug Delivery Device Annual Revenue by Company (2020-2022)
3.2.1 Global Active Transdermal Drug Delivery Device Revenue by Company (2020-2022)
3.2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Company (2020-2022)
3.3 Global Active Transdermal Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Active Transdermal Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Transdermal Drug Delivery Device Product Location Distribution
3.4.2 Players Active Transdermal Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Active Transdermal Drug Delivery Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Active Transdermal Drug Delivery Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Active Transdermal Drug Delivery Device Annual Revenue by Geographic Region
4.2 World Historic Active Transdermal Drug Delivery Device Market Size by Country/Region (2017-2022)
4.2.1 Global Active Transdermal Drug Delivery Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Active Transdermal Drug Delivery Device Annual Revenue by Country/Region
4.3 Americas Active Transdermal Drug Delivery Device Sales Growth
4.4 APAC Active Transdermal Drug Delivery Device Sales Growth
4.5 Europe Active Transdermal Drug Delivery Device Sales Growth
4.6 Middle East & Africa Active Transdermal Drug Delivery Device Sales Growth
5 AMERICAS
5.1 Americas Active Transdermal Drug Delivery Device Sales by Country
5.1.1 Americas Active Transdermal Drug Delivery Device Sales by Country (2017-2022)
5.1.2 Americas Active Transdermal Drug Delivery Device Revenue by Country (2017-2022)
5.2 Americas Active Transdermal Drug Delivery Device Sales by Type
5.3 Americas Active Transdermal Drug Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Transdermal Drug Delivery Device Sales by Region
6.1.1 APAC Active Transdermal Drug Delivery Device Sales by Region (2017-2022)
6.1.2 APAC Active Transdermal Drug Delivery Device Revenue by Region (2017-2022)
6.2 APAC Active Transdermal Drug Delivery Device Sales by Type
6.3 APAC Active Transdermal Drug Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Active Transdermal Drug Delivery Device by Country
7.1.1 Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2022)
7.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2022)
7.2 Europe Active Transdermal Drug Delivery Device Sales by Type
7.3 Europe Active Transdermal Drug Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Active Transdermal Drug Delivery Device by Country
8.1.1 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type
8.3 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Transdermal Drug Delivery Device
10.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
10.4 Industry Chain Structure of Active Transdermal Drug Delivery Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Transdermal Drug Delivery Device Distributors
11.3 Active Transdermal Drug Delivery Device Customer
12 WORLD FORECAST REVIEW FOR ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
12.1 Global Active Transdermal Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Active Transdermal Drug Delivery Device Forecast by Region (2023-2028)
12.1.2 Global Active Transdermal Drug Delivery Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Transdermal Drug Delivery Device Forecast by Type
12.7 Global Active Transdermal Drug Delivery Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Active Transdermal Drug Delivery Device Product Offered
13.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Noven Pharmaceuticals, Inc.
13.2.1 Noven Pharmaceuticals, Inc. Company Information
13.2.2 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Offered
13.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Noven Pharmaceuticals, Inc. Main Business Overview
13.2.5 Noven Pharmaceuticals, Inc. Latest Developments
13.3 Transdermal Corp.
13.3.1 Transdermal Corp. Company Information
13.3.2 Transdermal Corp. Active Transdermal Drug Delivery Device Product Offered
13.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Transdermal Corp. Main Business Overview
13.3.5 Transdermal Corp. Latest Developments
13.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
13.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
13.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Offered
13.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business Overview
13.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Active Transdermal Drug Delivery Device Product Offered
13.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 3M
13.6.1 3M Company Information
13.6.2 3M Active Transdermal Drug Delivery Device Product Offered
13.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 3M Main Business Overview
13.6.5 3M Latest Developments
13.7 Actavis, Inc.
13.7.1 Actavis, Inc. Company Information
13.7.2 Actavis, Inc. Active Transdermal Drug Delivery Device Product Offered
13.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Actavis, Inc. Main Business Overview
13.7.5 Actavis, Inc. Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Active Transdermal Drug Delivery Device Product Offered
13.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Boehringer Ingelheim GmbH
13.9.1 Boehringer Ingelheim GmbH Company Information
13.9.2 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Offered
13.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim GmbH Main Business Overview
13.9.5 Boehringer Ingelheim GmbH Latest Developments
13.10 Corium International, Inc.
13.10.1 Corium International, Inc. Company Information
13.10.2 Corium International, Inc. Active Transdermal Drug Delivery Device Product Offered
13.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Corium International, Inc. Main Business Overview
13.10.5 Corium International, Inc. Latest Developments
13.11 Echo Therapeutics, Inc.
13.11.1 Echo Therapeutics, Inc. Company Information
13.11.2 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Offered
13.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Echo Therapeutics, Inc. Main Business Overview
13.11.5 Echo Therapeutics, Inc. Latest Developments
13.12 GlaxoSmithKline plc
13.12.1 GlaxoSmithKline plc Company Information
13.12.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Offered
13.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GlaxoSmithKline plc Main Business Overview
13.12.5 GlaxoSmithKline plc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Active Transdermal Drug Delivery Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Active Transdermal Drug Delivery Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Active Transdermal Drug Delivery Device by Country/Region, 2017, 2022 & 2028
2.2 Active Transdermal Drug Delivery Device Segment by Type
2.2.1 Patches
2.2.2 Gels
2.3 Active Transdermal Drug Delivery Device Sales by Type
2.3.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
2.3.2 Global Active Transdermal Drug Delivery Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Active Transdermal Drug Delivery Device Sale Price by Type (2017-2022)
2.4 Active Transdermal Drug Delivery Device Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Home Use
2.5 Active Transdermal Drug Delivery Device Sales by Application
2.5.1 Global Active Transdermal Drug Delivery Device Sale Market Share by Application (2017-2022)
2.5.2 Global Active Transdermal Drug Delivery Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Active Transdermal Drug Delivery Device Sale Price by Application (2017-2022)
3 GLOBAL ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE BY COMPANY
3.1 Global Active Transdermal Drug Delivery Device Breakdown Data by Company
3.1.1 Global Active Transdermal Drug Delivery Device Annual Sales by Company (2020-2022)
3.1.2 Global Active Transdermal Drug Delivery Device Sales Market Share by Company (2020-2022)
3.2 Global Active Transdermal Drug Delivery Device Annual Revenue by Company (2020-2022)
3.2.1 Global Active Transdermal Drug Delivery Device Revenue by Company (2020-2022)
3.2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Company (2020-2022)
3.3 Global Active Transdermal Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Active Transdermal Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Transdermal Drug Delivery Device Product Location Distribution
3.4.2 Players Active Transdermal Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Active Transdermal Drug Delivery Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Active Transdermal Drug Delivery Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Active Transdermal Drug Delivery Device Annual Revenue by Geographic Region
4.2 World Historic Active Transdermal Drug Delivery Device Market Size by Country/Region (2017-2022)
4.2.1 Global Active Transdermal Drug Delivery Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Active Transdermal Drug Delivery Device Annual Revenue by Country/Region
4.3 Americas Active Transdermal Drug Delivery Device Sales Growth
4.4 APAC Active Transdermal Drug Delivery Device Sales Growth
4.5 Europe Active Transdermal Drug Delivery Device Sales Growth
4.6 Middle East & Africa Active Transdermal Drug Delivery Device Sales Growth
5 AMERICAS
5.1 Americas Active Transdermal Drug Delivery Device Sales by Country
5.1.1 Americas Active Transdermal Drug Delivery Device Sales by Country (2017-2022)
5.1.2 Americas Active Transdermal Drug Delivery Device Revenue by Country (2017-2022)
5.2 Americas Active Transdermal Drug Delivery Device Sales by Type
5.3 Americas Active Transdermal Drug Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Transdermal Drug Delivery Device Sales by Region
6.1.1 APAC Active Transdermal Drug Delivery Device Sales by Region (2017-2022)
6.1.2 APAC Active Transdermal Drug Delivery Device Revenue by Region (2017-2022)
6.2 APAC Active Transdermal Drug Delivery Device Sales by Type
6.3 APAC Active Transdermal Drug Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Active Transdermal Drug Delivery Device by Country
7.1.1 Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2022)
7.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2022)
7.2 Europe Active Transdermal Drug Delivery Device Sales by Type
7.3 Europe Active Transdermal Drug Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Active Transdermal Drug Delivery Device by Country
8.1.1 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type
8.3 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Transdermal Drug Delivery Device
10.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
10.4 Industry Chain Structure of Active Transdermal Drug Delivery Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Transdermal Drug Delivery Device Distributors
11.3 Active Transdermal Drug Delivery Device Customer
12 WORLD FORECAST REVIEW FOR ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
12.1 Global Active Transdermal Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Active Transdermal Drug Delivery Device Forecast by Region (2023-2028)
12.1.2 Global Active Transdermal Drug Delivery Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Transdermal Drug Delivery Device Forecast by Type
12.7 Global Active Transdermal Drug Delivery Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Active Transdermal Drug Delivery Device Product Offered
13.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Noven Pharmaceuticals, Inc.
13.2.1 Noven Pharmaceuticals, Inc. Company Information
13.2.2 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Offered
13.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Noven Pharmaceuticals, Inc. Main Business Overview
13.2.5 Noven Pharmaceuticals, Inc. Latest Developments
13.3 Transdermal Corp.
13.3.1 Transdermal Corp. Company Information
13.3.2 Transdermal Corp. Active Transdermal Drug Delivery Device Product Offered
13.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Transdermal Corp. Main Business Overview
13.3.5 Transdermal Corp. Latest Developments
13.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
13.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
13.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Offered
13.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business Overview
13.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Active Transdermal Drug Delivery Device Product Offered
13.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 3M
13.6.1 3M Company Information
13.6.2 3M Active Transdermal Drug Delivery Device Product Offered
13.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 3M Main Business Overview
13.6.5 3M Latest Developments
13.7 Actavis, Inc.
13.7.1 Actavis, Inc. Company Information
13.7.2 Actavis, Inc. Active Transdermal Drug Delivery Device Product Offered
13.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Actavis, Inc. Main Business Overview
13.7.5 Actavis, Inc. Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Active Transdermal Drug Delivery Device Product Offered
13.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Boehringer Ingelheim GmbH
13.9.1 Boehringer Ingelheim GmbH Company Information
13.9.2 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Offered
13.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim GmbH Main Business Overview
13.9.5 Boehringer Ingelheim GmbH Latest Developments
13.10 Corium International, Inc.
13.10.1 Corium International, Inc. Company Information
13.10.2 Corium International, Inc. Active Transdermal Drug Delivery Device Product Offered
13.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Corium International, Inc. Main Business Overview
13.10.5 Corium International, Inc. Latest Developments
13.11 Echo Therapeutics, Inc.
13.11.1 Echo Therapeutics, Inc. Company Information
13.11.2 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Offered
13.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Echo Therapeutics, Inc. Main Business Overview
13.11.5 Echo Therapeutics, Inc. Latest Developments
13.12 GlaxoSmithKline plc
13.12.1 GlaxoSmithKline plc Company Information
13.12.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Offered
13.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GlaxoSmithKline plc Main Business Overview
13.12.5 GlaxoSmithKline plc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Active Transdermal Drug Delivery Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Active Transdermal Drug Delivery Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patches
Table 4. Major Players of Gels
Table 5. Global Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 6. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 7. Global Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & ($ million)
Table 8. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2022)
Table 9. Global Active Transdermal Drug Delivery Device Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 11. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 12. Global Active Transdermal Drug Delivery Device Revenue by Application (2017-2022)
Table 13. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2022)
Table 14. Global Active Transdermal Drug Delivery Device Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Active Transdermal Drug Delivery Device Sales by Company (2020-2022) & (K Units)
Table 16. Global Active Transdermal Drug Delivery Device Sales Market Share by Company (2020-2022)
Table 17. Global Active Transdermal Drug Delivery Device Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Active Transdermal Drug Delivery Device Revenue Market Share by Company (2020-2022)
Table 19. Global Active Transdermal Drug Delivery Device Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Active Transdermal Drug Delivery Device Producing Area Distribution and Sales Area
Table 21. Players Active Transdermal Drug Delivery Device Products Offered
Table 22. Active Transdermal Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Active Transdermal Drug Delivery Device Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Active Transdermal Drug Delivery Device Sales Market Share Geographic Region (2017-2022)
Table 27. Global Active Transdermal Drug Delivery Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Active Transdermal Drug Delivery Device Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Active Transdermal Drug Delivery Device Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Active Transdermal Drug Delivery Device Sales Market Share by Country/Region (2017-2022)
Table 31. Global Active Transdermal Drug Delivery Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Active Transdermal Drug Delivery Device Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 34. Americas Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 35. Americas Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 37. Americas Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 38. Americas Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 39. Americas Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 40. Americas Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 41. APAC Active Transdermal Drug Delivery Device Sales by Region (2017-2022) & (K Units)
Table 42. APAC Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Table 43. APAC Active Transdermal Drug Delivery Device Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Active Transdermal Drug Delivery Device Revenue Market Share by Region (2017-2022)
Table 45. APAC Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 46. APAC Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 47. APAC Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 48. APAC Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 49. Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 50. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 51. Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 53. Europe Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 54. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 55. Europe Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 56. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Active Transdermal Drug Delivery Device
Table 66. Key Market Challenges & Risks of Active Transdermal Drug Delivery Device
Table 67. Key Industry Trends of Active Transdermal Drug Delivery Device
Table 68. Active Transdermal Drug Delivery Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Active Transdermal Drug Delivery Device Distributors List
Table 71. Active Transdermal Drug Delivery Device Customer List
Table 72. Global Active Transdermal Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Active Transdermal Drug Delivery Device Sales Market Forecast by Region
Table 74. Global Active Transdermal Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Active Transdermal Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Active Transdermal Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Active Transdermal Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Active Transdermal Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Active Transdermal Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Active Transdermal Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Active Transdermal Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Active Transdermal Drug Delivery Device Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Active Transdermal Drug Delivery Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Active Transdermal Drug Delivery Device Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Active Transdermal Drug Delivery Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novartis AG Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis AG Active Transdermal Drug Delivery Device Product Offered
Table 94. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Novartis AG Main Business
Table 96. Novartis AG Latest Developments
Table 97. Noven Pharmaceuticals, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 98. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 99. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Noven Pharmaceuticals, Inc. Main Business
Table 101. Noven Pharmaceuticals, Inc. Latest Developments
Table 102. Transdermal Corp. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 103. Transdermal Corp. Active Transdermal Drug Delivery Device Product Offered
Table 104. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Transdermal Corp. Main Business
Table 106. Transdermal Corp. Latest Developments
Table 107. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Offered
Table 109. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business
Table 111. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
Table 112. Mylan N.V. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan N.V. Active Transdermal Drug Delivery Device Product Offered
Table 114. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Mylan N.V. Main Business
Table 116. Mylan N.V. Latest Developments
Table 117. 3M Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 118. 3M Active Transdermal Drug Delivery Device Product Offered
Table 119. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. 3M Main Business
Table 121. 3M Latest Developments
Table 122. Actavis, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 123. Actavis, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 124. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Actavis, Inc. Main Business
Table 126. Actavis, Inc. Latest Developments
Table 127. Bayer AG Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 128. Bayer AG Active Transdermal Drug Delivery Device Product Offered
Table 129. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Bayer AG Main Business
Table 131. Bayer AG Latest Developments
Table 132. Boehringer Ingelheim GmbH Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Offered
Table 134. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim GmbH Main Business
Table 136. Boehringer Ingelheim GmbH Latest Developments
Table 137. Corium International, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 138. Corium International, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 139. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Corium International, Inc. Main Business
Table 141. Corium International, Inc. Latest Developments
Table 142. Echo Therapeutics, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 143. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 144. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Echo Therapeutics, Inc. Main Business
Table 146. Echo Therapeutics, Inc. Latest Developments
Table 147. GlaxoSmithKline plc Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 148. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Offered
Table 149. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. GlaxoSmithKline plc Main Business
Table 151. GlaxoSmithKline plc Latest Developments
Table 1. Active Transdermal Drug Delivery Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Active Transdermal Drug Delivery Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patches
Table 4. Major Players of Gels
Table 5. Global Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 6. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 7. Global Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & ($ million)
Table 8. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2022)
Table 9. Global Active Transdermal Drug Delivery Device Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 11. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 12. Global Active Transdermal Drug Delivery Device Revenue by Application (2017-2022)
Table 13. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2022)
Table 14. Global Active Transdermal Drug Delivery Device Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Active Transdermal Drug Delivery Device Sales by Company (2020-2022) & (K Units)
Table 16. Global Active Transdermal Drug Delivery Device Sales Market Share by Company (2020-2022)
Table 17. Global Active Transdermal Drug Delivery Device Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Active Transdermal Drug Delivery Device Revenue Market Share by Company (2020-2022)
Table 19. Global Active Transdermal Drug Delivery Device Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Active Transdermal Drug Delivery Device Producing Area Distribution and Sales Area
Table 21. Players Active Transdermal Drug Delivery Device Products Offered
Table 22. Active Transdermal Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Active Transdermal Drug Delivery Device Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Active Transdermal Drug Delivery Device Sales Market Share Geographic Region (2017-2022)
Table 27. Global Active Transdermal Drug Delivery Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Active Transdermal Drug Delivery Device Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Active Transdermal Drug Delivery Device Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Active Transdermal Drug Delivery Device Sales Market Share by Country/Region (2017-2022)
Table 31. Global Active Transdermal Drug Delivery Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Active Transdermal Drug Delivery Device Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 34. Americas Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 35. Americas Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 37. Americas Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 38. Americas Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 39. Americas Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 40. Americas Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 41. APAC Active Transdermal Drug Delivery Device Sales by Region (2017-2022) & (K Units)
Table 42. APAC Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Table 43. APAC Active Transdermal Drug Delivery Device Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Active Transdermal Drug Delivery Device Revenue Market Share by Region (2017-2022)
Table 45. APAC Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 46. APAC Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 47. APAC Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 48. APAC Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 49. Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 50. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 51. Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 53. Europe Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 54. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 55. Europe Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 56. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Active Transdermal Drug Delivery Device
Table 66. Key Market Challenges & Risks of Active Transdermal Drug Delivery Device
Table 67. Key Industry Trends of Active Transdermal Drug Delivery Device
Table 68. Active Transdermal Drug Delivery Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Active Transdermal Drug Delivery Device Distributors List
Table 71. Active Transdermal Drug Delivery Device Customer List
Table 72. Global Active Transdermal Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Active Transdermal Drug Delivery Device Sales Market Forecast by Region
Table 74. Global Active Transdermal Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Active Transdermal Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Active Transdermal Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Active Transdermal Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Active Transdermal Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Active Transdermal Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Active Transdermal Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Active Transdermal Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Active Transdermal Drug Delivery Device Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Active Transdermal Drug Delivery Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Active Transdermal Drug Delivery Device Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Active Transdermal Drug Delivery Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novartis AG Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis AG Active Transdermal Drug Delivery Device Product Offered
Table 94. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Novartis AG Main Business
Table 96. Novartis AG Latest Developments
Table 97. Noven Pharmaceuticals, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 98. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 99. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Noven Pharmaceuticals, Inc. Main Business
Table 101. Noven Pharmaceuticals, Inc. Latest Developments
Table 102. Transdermal Corp. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 103. Transdermal Corp. Active Transdermal Drug Delivery Device Product Offered
Table 104. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Transdermal Corp. Main Business
Table 106. Transdermal Corp. Latest Developments
Table 107. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Offered
Table 109. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business
Table 111. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
Table 112. Mylan N.V. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan N.V. Active Transdermal Drug Delivery Device Product Offered
Table 114. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Mylan N.V. Main Business
Table 116. Mylan N.V. Latest Developments
Table 117. 3M Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 118. 3M Active Transdermal Drug Delivery Device Product Offered
Table 119. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. 3M Main Business
Table 121. 3M Latest Developments
Table 122. Actavis, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 123. Actavis, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 124. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Actavis, Inc. Main Business
Table 126. Actavis, Inc. Latest Developments
Table 127. Bayer AG Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 128. Bayer AG Active Transdermal Drug Delivery Device Product Offered
Table 129. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Bayer AG Main Business
Table 131. Bayer AG Latest Developments
Table 132. Boehringer Ingelheim GmbH Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Offered
Table 134. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim GmbH Main Business
Table 136. Boehringer Ingelheim GmbH Latest Developments
Table 137. Corium International, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 138. Corium International, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 139. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Corium International, Inc. Main Business
Table 141. Corium International, Inc. Latest Developments
Table 142. Echo Therapeutics, Inc. Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 143. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Offered
Table 144. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Echo Therapeutics, Inc. Main Business
Table 146. Echo Therapeutics, Inc. Latest Developments
Table 147. GlaxoSmithKline plc Basic Information, Active Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 148. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Offered
Table 149. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. GlaxoSmithKline plc Main Business
Table 151. GlaxoSmithKline plc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Active Transdermal Drug Delivery Device
Figure 2. Active Transdermal Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Transdermal Drug Delivery Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Active Transdermal Drug Delivery Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Active Transdermal Drug Delivery Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patches
Figure 10. Product Picture of Gels
Figure 11. Global Active Transdermal Drug Delivery Device Sales Market Share by Type in 2021
Figure 12. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2022)
Figure 13. Active Transdermal Drug Delivery Device Consumed in Clinic
Figure 14. Global Active Transdermal Drug Delivery Device Market: Clinic (2017-2022) & (K Units)
Figure 15. Active Transdermal Drug Delivery Device Consumed in Hospital
Figure 16. Global Active Transdermal Drug Delivery Device Market: Hospital (2017-2022) & (K Units)
Figure 17. Active Transdermal Drug Delivery Device Consumed in Home Use
Figure 18. Global Active Transdermal Drug Delivery Device Market: Home Use (2017-2022) & (K Units)
Figure 19. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Figure 20. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application in 2021
Figure 21. Active Transdermal Drug Delivery Device Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Active Transdermal Drug Delivery Device Revenue Market Share by Company in 2021
Figure 23. Global Active Transdermal Drug Delivery Device Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Active Transdermal Drug Delivery Device Revenue Market Share by Geographic Region in 2021
Figure 25. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Figure 26. Global Active Transdermal Drug Delivery Device Revenue Market Share by Country/Region in 2021
Figure 27. Americas Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 28. Americas Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 29. APAC Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 30. APAC Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 31. Europe Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 32. Europe Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 35. Americas Active Transdermal Drug Delivery Device Sales Market Share by Country in 2021
Figure 36. Americas Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2021
Figure 37. United States Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Active Transdermal Drug Delivery Device Sales Market Share by Region in 2021
Figure 42. APAC Active Transdermal Drug Delivery Device Revenue Market Share by Regions in 2021
Figure 43. China Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country in 2021
Figure 50. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2021
Figure 51. Germany Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2021
Figure 58. Egypt Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Active Transdermal Drug Delivery Device in 2021
Figure 64. Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
Figure 65. Industry Chain Structure of Active Transdermal Drug Delivery Device
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Active Transdermal Drug Delivery Device
Figure 2. Active Transdermal Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Transdermal Drug Delivery Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Active Transdermal Drug Delivery Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Active Transdermal Drug Delivery Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patches
Figure 10. Product Picture of Gels
Figure 11. Global Active Transdermal Drug Delivery Device Sales Market Share by Type in 2021
Figure 12. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2022)
Figure 13. Active Transdermal Drug Delivery Device Consumed in Clinic
Figure 14. Global Active Transdermal Drug Delivery Device Market: Clinic (2017-2022) & (K Units)
Figure 15. Active Transdermal Drug Delivery Device Consumed in Hospital
Figure 16. Global Active Transdermal Drug Delivery Device Market: Hospital (2017-2022) & (K Units)
Figure 17. Active Transdermal Drug Delivery Device Consumed in Home Use
Figure 18. Global Active Transdermal Drug Delivery Device Market: Home Use (2017-2022) & (K Units)
Figure 19. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2022)
Figure 20. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application in 2021
Figure 21. Active Transdermal Drug Delivery Device Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Active Transdermal Drug Delivery Device Revenue Market Share by Company in 2021
Figure 23. Global Active Transdermal Drug Delivery Device Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Active Transdermal Drug Delivery Device Revenue Market Share by Geographic Region in 2021
Figure 25. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
Figure 26. Global Active Transdermal Drug Delivery Device Revenue Market Share by Country/Region in 2021
Figure 27. Americas Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 28. Americas Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 29. APAC Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 30. APAC Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 31. Europe Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 32. Europe Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Active Transdermal Drug Delivery Device Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Active Transdermal Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 35. Americas Active Transdermal Drug Delivery Device Sales Market Share by Country in 2021
Figure 36. Americas Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2021
Figure 37. United States Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Active Transdermal Drug Delivery Device Sales Market Share by Region in 2021
Figure 42. APAC Active Transdermal Drug Delivery Device Revenue Market Share by Regions in 2021
Figure 43. China Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country in 2021
Figure 50. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2021
Figure 51. Germany Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2021
Figure 58. Egypt Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Active Transdermal Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Active Transdermal Drug Delivery Device in 2021
Figure 64. Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
Figure 65. Industry Chain Structure of Active Transdermal Drug Delivery Device
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
